New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
14:32 EDTPCYCPharmacyclics estimates raised ahead of Q2 report at Goldman
Goldman raised Pharmacyclics' Q2 Imbruvica US sales estimate to $93M from $82M, vs. consensus of $88M and 2014 to $409M from $383M based on IMS data. The firm rates shares a Buy with a $162 price target.
News For PCYC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 16, 2015
15:31 EDTPCYCPharmacyclics resumes, up 0.6% to $256.58 after HELIOS hits primary endpoint
Subscribe for More Information
15:08 EDTPCYCPharmacyclics to resume trading at 3:30 pm EDT
Subscribe for More Information
15:04 EDTPCYCPharmacyclics says committee recommends unblinding after primary endpoint met
Subscribe for More Information
14:55 EDTPCYCPharmacyclics trading halted, pending news

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use